Strand Life Sciences launches ‘Strand Genomic Wellness’

Strand Life Sciences launches ‘Strand Genomic Wellness’

Strand’s new offering will help people better understand and manage diseases through genomic sequencing

  • By IPP Bureau | November 18, 2022

Strand Life Sciences, a genomics-based research and diagnostics company, has launched ‘Strand Genomic Wellness’, a new line of genomic-based tests for preventive wellness. Launched at Bengaluru Tech Summit, this new offering from Strand can help individuals understand and manage their disease better.

As the first offering of the program, Strand has introduced the  ‘Genomic Health Insight’ report to help individuals understand how their personal genomic variations  might influence their risk for a broad range of diseases with 30-100% heritability. This knowledge can help individuals work with their doctors to manage their risk with proactive wellness measures.

A recent study published by Mayo Clinic Proceedings indicates that nearly 1 in 8 people who underwent predictive genomic testing found that they had a genetic risk for a health condition and may be able to manage it better with preventive care.  Rising adoption of healthier lifestyles and increasing awareness of new healthcare programs and advancements are expected to drive increasing demand for predictive genetic testing.

Commenting on the new launch, Dr. Ramesh Hariharan, CEO & Co-Founder, Strand Life Sciences, said, “We are excited to bring our 22 years of experience in Genomics and Bioinformatics to help individuals use genomics-based insights to proactively manage their wellness. Genomics is advancing at a breakneck pace, and the Genomic Wellness initiative will bring these advances to the Indian consumer, beginning with inherited insights and eventually covering evolving insights that reflect the dynamic of the ageing body.”

Upcoming E-conference

Other Related stories